UiPath (NYSE:PATH) Stock Price Up 0.5%

UiPath Inc. (NYSE:PATHGet Free Report) shares shot up 0.5% during trading on Wednesday . The company traded as high as $19.91 and last traded at $19.65. 1,215,390 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 8,732,511 shares. The stock had previously closed at $19.55.

Analyst Ratings Changes

A number of brokerages have recently commented on PATH. Morgan Stanley lifted their price objective on shares of UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, March 14th. DA Davidson raised their target price on shares of UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. TD Cowen raised their target price on shares of UiPath from $25.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, March 14th. Scotiabank raised their target price on shares of UiPath from $29.00 to $30.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 14th. Finally, Bank of America boosted their price objective on shares of UiPath from $26.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, UiPath currently has a consensus rating of “Moderate Buy” and an average target price of $27.41.

Check Out Our Latest Report on UiPath

UiPath Trading Up 0.8 %

The company’s 50-day simple moving average is $22.55 and its 200-day simple moving average is $21.56. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of -115.58 and a beta of 0.96.

UiPath (NYSE:PATHGet Free Report) last announced its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. On average, equities research analysts expect that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last three months, insiders have sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Mark Sheptoff Financial Planning LLC bought a new position in shares of UiPath in the fourth quarter valued at $25,000. HighMark Wealth Management LLC purchased a new stake in shares of UiPath in the fourth quarter valued at about $27,000. Cypress Capital Management LLC WY purchased a new stake in shares of UiPath in the fourth quarter valued at about $29,000. GAMMA Investing LLC purchased a new stake in shares of UiPath in the fourth quarter valued at about $36,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of UiPath in the fourth quarter valued at about $40,000. 62.50% of the stock is owned by institutional investors.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Recommended Stories

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.